GLYC
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Jun 2, 04:18 PM (EDT)
Capitalization
13.55M
58 days until earnings call
LTRN
Price
$3.19
Change
+$0.14 (+4.59%)
Updated
Jun 2, 04:59 PM (EDT)
Capitalization
32.89M
65 days until earnings call
Interact to see
Advertisement

GLYC vs LTRN

Header iconGLYC vs LTRN Comparison
Open Charts GLYC vs LTRNBanner chart's image
GlycoMimetics
Price$0.20
Change-$0.01 (-4.76%)
Volume$10K
Capitalization13.55M
Lantern Pharma
Price$3.19
Change+$0.14 (+4.59%)
Volume$274
Capitalization32.89M
GLYC vs LTRN Comparison Chart
Loading...
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLYC vs. LTRN commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLYC is a Hold and LTRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 02, 2025
Stock price -- (GLYC: $0.21 vs. LTRN: $3.05)
Brand notoriety: GLYC and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLYC: 145% vs. LTRN: 71%
Market capitalization -- GLYC: $13.55M vs. LTRN: $32.89M
GLYC [@Biotechnology] is valued at $13.55M. LTRN’s [@Biotechnology] market capitalization is $32.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLYC’s FA Score shows that 0 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • GLYC’s FA Score: 0 green, 5 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, LTRN is a better buy in the long-term than GLYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLYC’s TA Score shows that 5 TA indicator(s) are bullish while LTRN’s TA Score has 3 bullish TA indicator(s).

  • GLYC’s TA Score: 5 bullish, 6 bearish.
  • LTRN’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GLYC is a better buy in the short-term than LTRN.

Price Growth

GLYC (@Biotechnology) experienced а -14.05% price change this week, while LTRN (@Biotechnology) price change was -7.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.16%. For the same industry, the average monthly price growth was +3.07%, and the average quarterly price growth was -0.47%.

Reported Earning Dates

GLYC is expected to report earnings on Jul 30, 2025.

LTRN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LTRN($32.9M) has a higher market cap than GLYC($13.5M). LTRN YTD gains are higher at: -4.389 vs. GLYC (-15.703). LTRN has higher annual earnings (EBITDA): -21.18M vs. GLYC (-32.47M). LTRN has more cash in the bank: 28.1M vs. GLYC (10.7M). GLYC has less debt than LTRN: GLYC (66.8K) vs LTRN (291K). GLYC (0) and LTRN (0) have equivalent revenues.
GLYCLTRNGLYC / LTRN
Capitalization13.5M32.9M41%
EBITDA-32.47M-21.18M153%
Gain YTD-15.703-4.389358%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.7M28.1M38%
Total Debt66.8K291K23%
FUNDAMENTALS RATINGS
GLYC: Fundamental Ratings
GLYC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLYCLTRN
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 22 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHKP228.884.49
+2.00%
Check Point Software Technologies Ltd
KTB68.60-0.64
-0.92%
Kontoor Brands
INVE3.27-0.04
-1.21%
Identiv
AXL4.39-0.07
-1.57%
American Axle & Manufacturing Holdings
RLYB0.31-0.01
-3.13%
Rallybio Corp